Ropeginterferon Alfa-2b Listed in NCCN Guidelines as A Preferred Polycythemia Vera Treatment

Press/Media

Period	29 May 2023

Media coverage

Title	Ropeginterferon Alfa-2b Listed in NCCN Guidelines as A Preferred Polycythemia Vera Treatment
Media name/outlet	Oncology Nursing News
Country/Territory	United States
Date	29/05/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=68BS-8SV1-F0CR-J0TR-00000-00
Persons	John Mascarenhas